$AHCO Cashflow Statement | Understand Stock

$AHCO

$5.93 -$0.09 (1.5%) Close

$AHCO Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net (loss) income
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization, including patient equipment depreciation
Goodwill impairment
Equity-based compensation
Change in fair value of warrant liability
Change in fair value of contingent consideration common shares liability
Reduction in the carrying amount of operating lease right-of-use assets
Reduction in the carrying amount of finance lease right-of-use assets
Deferred income tax expense (benefit)
Change in fair value of interest rate swaps, net of reclassification adjustment
Amortization of intangible assets
Amortization of deferred financing costs
Write-off of deferred financing costs
Loss on extinguishment of debt from prepayment penalty
Loss on extinguishment of debt
Payment of contingent consideration from an acquisition
Gain on sale of businesses (note 4)
Other
Changes in operating assets and liabilities, net of effects from acquisitions:
Accounts receivable
Inventory
Prepaid and other assets
Operating lease obligations
Operating liabilities
Net cash provided by operating activities
Cash flows from investing activities:
Purchases of equipment and other fixed assets
Payments for business acquisitions, net of cash acquired
Proceeds from the sale of businesses, net of cash disposed
Proceeds from the sale of assets
Payments for cost method investments
Proceeds from sale of investment
Receipt of contingent consideration from the sale of assets
Net cash used in investing activities

Cash flows from financing activities:
Repayments on long-term debt and lines of credit
Proceeds from borrowings on lines of credit
Repayments of finance lease obligations
Payments for shares purchased under share repurchase program
Proceeds from the exercise of stock options
Proceeds received in connection with employee stock purchase plan
Proceeds from the issuance of senior unsecured notes
Proceeds from the issuance of Class A Common Stock
Payments for equity issuance costs
Public Offering
Total payments for equity issuance costs

Payments of debt financing costs
Payments for debt prepayment penalties
Proceeds from the sale of Class A Common Stock and Series A Preferred Stock
Proceeds from the exercise of warrants
Exchange of Class B Common Stock for cash
Payment for exercise of call option relating to the Put/Call Agreement
Distributions to noncontrolling interests
Payments for tax withholdings from vesting of restricted stock units
Payments of contingent consideration and deferred purchase price from acquisitions
Net cash used in financing activities

Net (decrease) increase in cash
Cash at beginning of period
Cash at end of period
Supplemental disclosures:
Cash paid for interest
Cash paid for income taxes, net of refunds
Noncash investing and financing activities:
Equipment acquired under finance lease obligations
Unpaid equipment and other fixed asset purchases at end of period
Assets subject to operating lease obligations
Operating leases
Operating lease obligations
Write-off of assets subject to operating lease obligations
Write-off of operating lease obligations
Assets subject to finance lease obligations
Finance lease obligations
Equity consideration issued in connection with acquisitions
Contingent purchase price in connection with acquisitions
Write-off of assets subject to finance lease obligations
Write-off of finance lease obligations
Deferred purchase price in connection with acquisitions

Comments